Soft-tissue augmentation with injectable alginate and syngeneic fibroblasts

Plastic and Reconstructive Surgery

Volumn 105, Issue 6, 2000, Pages 2049-2058

  Marler, Jennifer J ^a   Guha, Amrita ^b   Rowley, Jonathan ^b   Koka, Rahul ^b   Mooney, David ^b   Upton, Joseph ^b   Vacanti, Joseph P ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CALCIUM ALGINATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL POPULATION; CELL VOLUME; CONTROLLED STUDY; FIBROBLAST; HYDROGEL; MALE; NONHUMAN; PLASTIC SURGERY; PRIORITY JOURNAL; RAT; VASCULARIZATION;

EID: 0034099047     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200005000-00020     Document Type: Article

References (52)

1. Langer, R., and Vacanti, J. P. Tissue engineering. Science 260: 920, 1993.
2. Rowley, J. A., Madlambayan, G., and Mooney, D. J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20: 45, 1999.
3. Gersuny, R. Ueber eine subcutane Prosthese. Z. Heilkunde 199: 1900.
4. Eckstein, H. Ueber subkutane und submuköse Hartparaffinprosthesen. Dtsche. Med. Wochenschr. 28: 573, 1902.
5. Conway, H., and Goulian, D., Jr. Experience with an injectable Silastic RTV as a subcutaneous prosthetic material. Plast. Reconstr. Surg. 32: 294, 1963.
6. Ashley, F. L., Thompson, D. P., and Henderson, T. H. Augmentation of surface contour by subcutaneous injections of silicone fluid. Plast. Reconstr. Surg. 51: 8, 1973.
7. Webster, R. C., et al. Injectable silicone: Report of 17,000 facial treatments since 1962. Am. J. Cosmetic Surg. 3: 41, 1986.
8. Lemperle, G., Ou, H., Charrier, U., et al. PMMA microspheres for intradermal implantation: Part I. An-imal research. Ann. Plast. Surg. 26: 57, 1991.
9. Lemperle, G., Hazan-Gauthier, N., and Lemperle, M. PMMA microspheres (Artecoll) for skin and soft-tissue augmentation: Part II. Clinical investigations. Plast. Reconstr. Surg. 96: 627, 1995.
10. Ersek, R. A., and Beisang, A. A., III. Bioplastique: A new textured copolymer microparticle promises permanence in soft-tissue augmentation. Plast. Reconstr. Surg. 87: 693, 1991.
11. Ersek, R. A., Stovall, R. B., and Vazquez-Salisbury, A. Chin augmentation using minimally invasive technique and Bioplastique. Plast. Reconstr. Surg. 95: 985, 1995.
12. Knapp, T. R., Kaplan, E. N., and Daniels J. R. Injectable collagen for soft tissue augmentation. Plast. Reconstr. Surg. 60: 398, 1977.
13. Cooperman, L. S., Mackinnon, V., Bechler, G., and Pharriss, B. B. Injectable collagen: A six-year clinical investigation. Aesthetic Plast. Surg. 9: 145, 1985.
14. Elson, M. L. Clinical assessment of Zyplast implant: A year of experience for soft tissue contour correction. J. Am. Acad. Dermatol. 18: 707, 1988.
15. Klein, A. W. Indications and implantation techniques for the various formulations of injectable collagen. J. Dermatol. Surg. Oncol. 14 (Suppl. 1): 27, 1988.
16. Fagien, S. Autologen: Autologous Injectable Dermal Collagen for Facial Soft Tissue Augmentation. Presentation at the British Association of Aesthetic Plastic Surgery. The Royal College of Surgeons, London, England, December 3, 1996.
17. Rosen, T. Fibrel, a new implant material. J. Am. Acad. Dermatol. 16: 155, 1987.
18. Monheit, G. D. Fibrel injection techniques in cutaneous scars for soft tissue augmentation and wrinkles. Cosmetic Dermatol. 5: 10, 1992.
19. Balazs, E. A., Denlinger, J. L., Leshchiner, E., et al. Hylan: Hyaluronan derivatives for soft tissue repair and augmentation. Biotech. U.S.A. Nov. 14-16: 442, 1988.
20. Larsen, N. E., Pollack, C. T., Reiner, K., Leshchiner, E., and Balazs, E. A. Hylan gel biomaterial: Dermal and immunologiv compatibility. J. Biomed. Mater. Res. 27: 1129, 1993.
21. Billings, E., Jr., and May, J. W., Jr. Historical review and present status of free graft autotransplantation in plastic and reconstructive surgery. Plast. Reconstr. Surg. 83: 368, 1989.
22. Horl, H.W., Feller, A.M., and Biemer, E. Technique for liposuction fat reimplantation and long-term evaluation by magnetic resonance imaging. Ann. Plast. Surg. 26: 248, 1991.
23. Illouz, Y. G. The fat cell "graft": A new technique to fill depressions. Plast. Reconstr. Surg. 78: 122, 1986.
24. Sutherland, I. W. Alginates. In D. Byrom (Ed.), Biomaterials: Novel Materials from Biological Sources. New York: Stockton Press, 1991.
25. Gilchrist, T., and Martin, A. M. Wound treatment with Sorbsan: An alginate fibre dressing. Biomaterials 4: 317, 1983.
26. Agren, M. S. Four alginate dressings in the treatment of partial thickness wounds: A comparative experimental study. Br. J. Plast. Surg. 49: 129, 1996.
27. Fathy, M., Safwat, S. M., el-Shanawany, S. M., Shawky Tous, S., and Otagiri, M. Preparation and evaluation of beads made of different calcium alginate compositions for oral sustained release of tiaramide. Pharm. Dev. Technol. 3: 355, 1998.
28. Torre, M. L., Giunchedi, P., Maggi, L., Stefli, R., Machiste, E. O., and Conte, U. Formulation and characterization of calcium alginate beads containing ampicillin. Pharm. Dev. Technol. 3: 193, 1998.
29. Atala, A., Cima, L. G., Kim, W., et al. Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J. Urol. 150: 745, 1993.
30. Atala, A., Kim, W., Paige, K. T., Vacanti, C. A., and Retik, A. B. Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension. J. Urol. 152: 641, 1994.
31. Hauselmann, H. J., Masuda, K., Hunziker, E. B., et al. Adult human chondrocytes cultured in alginate form a matrix similar to native human articular cartilage. Am. J. Physiol. 271: C742, 1996.
32. Garfinkel, M. R., Harland, R. C., and Opara, E. C. Optimization of the microencapsulated islet for transplantation. J. Surg. Res. 76: 7, 1998.
33. JoIy, A., Desjardins, J. F., Fremond, B., et al. Survival, proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: A step toward a reliable bioartificial liver. Transplantation 63: 795, 1997.
34. Hasse, C., Klock, G., Zielke, A.,et al. Transplantation of parathyroid tissue in experimental hypoparathyroidism: In vitro and in vivo function of parathyroid tissue microencapsulated with a novel amitogenic alginate. Int. J. Artif. Organs 19: 735, 1996.
35. Peirone, M., Ross, C. J., Hortelano, G., Brash, J. L., and Chang, P. L. Encapsulation of various recombinant mammalian cell types in different alginate microcapsules. J. Biomed. Mater. Res. 42: 587, 1998.
36. Ibarra, C., Jannetta, C., Vacanti, C. A., et al. Tissue engineered meniscus: A potential new alternative to allogeneic meniscus transplantation. Transplant. Proc. 29: 986, 1997.
37. Lee, J. H., Kim, W. G., Kim, S. S., Lee, J. H., and Lee, H. B. Development and characterization of an alginate-impregnated polyester vascular graft. J. Biomed. Mater. Res. 36: 200, 1997.
38. Sellke, F. W., Laham, R. J., Edelman, E. R., Pearlman, J. D., and Simons, M. Therapeutic angiogenesis with basic fibroblast growth factor: Technique and early results. Ann. Thorac. Surg. 65: 1540, 1998.
39. Bellon, J. M., Bujan, J., Contreras, L., Hernando, A., and Jurado, F. Macrophage response to experimental implantation of polypropylene prostheses. Eur. Surg. Res. 26: 46, 1994.
40. Aragona, F., D'Urso, L., and Marcolongo, R. Immunologie aspects of bovine injectable collagen in humans: A review. Eur. Urol. 33: 129, 1998.
41. Matthew, I. R., Browne, R. M., Frame, J. W., and Millar, B. G. Subperiosteal behaviour of alginate and cellulose wound dressing materials. Biomaterials 16: 275, 1995.
42. Bergsma, J. E., Rozema, F. R., Bos, R. R., Boering, G., de Bruijn, W. C., and Pennings, A.J. In vivo degradation and biocompatibility study of in vitro pre-degraded as-polymerized polylactide particles. Biomaterials 16: 267, 1995.
43. Ozgentas, H. E., Pindur, A., Spira, M., Liu, B., and Shenaq, S. A comparison of soft-tissue substitutes. Ann. Plast. Surg. 33: 171, 1994.
44. Jansen, J. A., Dhert, W.J., van der Waerden, J. P., and von Recum, A. F. Semi-quantitative and qualitative histologic analysis method for the evaluation of implant biocompatibility. J. Invest. Surg. 7: 123, 1994.
45. Behling, C. A., and Spector, M. Quantitative characterization of cells at the interface of long-term implants of selected polymers. J. Biomed. Mater. Res. 20: 653, 1986.
46. Siebers, U., Horcher, A., Bretzel, R. G., Federlin, K., and Zekorn, T. Alginate-based microcapsules for immunoprotected islet transplantation. Ann. N. Y. Acad. Sci. 831: 304, 1997.
47. Klock, G., Pfeffermann, A., Ryser, C., et al. Biocompatibility of mannuronic acid-rich alginates. Biomaterials 18: 707, 1997.
48. De Vos, P., De Haan, B., and Van Schilfgaarde, R. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials 18: 273, 1997.
49. Clayton, H. A., London, N. J., Colloby, P. S., Bell, P. R., and James, R. F. The effect of capsule composition on the biocompatibility of alginate-poly-1-lysine capsules. J. Microencapsul. 8: 221, 1991.
50. Zimmermann, U., Klock, G., Federlin, K., et al. Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis 13: 269, 1992.
51. Zekorn, T., Klock, G., Horcher, A., et al. Lymphoid activation by different crude alginates and the effect of purification. Transplant. Proc. 24: 2952, 1992.
52. Hasse, C., Zielke, A., Klock, G., et al. Amitogenic alginates: Key to first clinical application of microencapsulation technology. World J. Surg. 22: 659, 1998.